Zheng JN - Search Results

1

CUL1 promotes breast cancer metastasis through regulating EZH2-induced the autocrine expression of the cytokines CXCL8 and IL11.

Huang YF, Zhang Z, Zhang M, Chen YS, Song J, Hou PF, Yong HM, Zheng JN, Bai J. Huang YF, et al. Among authors: zheng jn. Cell Death Dis. 2018 Dec 18;10(1):2. doi: 10.1038/s41419-018-1258-6. Cell Death Dis. 2018. PMID: 30578411 Free PMC article.

2

RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.

Mei PJ, Bai J, Liu H, Li C, Wu YP, Yu ZQ, Zheng JN. Mei PJ, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2011 Dec;137(12):1823-30. doi: 10.1007/s00432-011-1063-4. Epub 2011 Sep 16. J Cancer Res Clin Oncol. 2011. PMID: 21922326

3

BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.

Bai J, Mei PJ, Liu H, Li C, Li W, Wu YP, Yu ZQ, Zheng JN. Bai J, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2012 Jun;138(6):991-8. doi: 10.1007/s00432-012-1172-8. Epub 2012 Feb 24. J Cancer Res Clin Oncol. 2012. PMID: 22362300

4

RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.

Chen F, Bai J, Li W, Mei P, Liu H, Li L, Pan Z, Wu Y, Zheng J. Chen F, et al. PLoS One. 2013;8(2):e56241. doi: 10.1371/journal.pone.0056241. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457532 Free PMC article.

5

BRG1 is a prognostic marker and potential therapeutic target in human breast cancer.

Bai J, Mei P, Zhang C, Chen F, Li C, Pan Z, Liu H, Zheng J. Bai J, et al. PLoS One. 2013;8(3):e59772. doi: 10.1371/journal.pone.0059772. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533649 Free PMC article.

6

Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer.

Bai J, Yong HM, Chen FF, Mei PJ, Liu H, Li C, Pan ZQ, Wu YP, Zheng JN. Bai J, et al. Among authors: zheng jn. Ann Oncol. 2013 Aug;24(8):2016-22. doi: 10.1093/annonc/mdt147. Epub 2013 Apr 16. Ann Oncol. 2013. PMID: 23592700 Free article.

7

RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.

Bai J, Yong HM, Chen FF, Song WB, Li C, Liu H, Zheng JN. Bai J, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2013 Nov;139(11):1813-23. doi: 10.1007/s00432-013-1498-x. Epub 2013 Sep 4. J Cancer Res Clin Oncol. 2013. PMID: 24002642

8

The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.

Xu W, Liu H, Song J, Fu HX, Qiu L, Zhang BF, Li HZ, Bai J, Zheng JN. Xu W, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2013 Nov;139(11):1845-52. doi: 10.1007/s00432-013-1500-7. Epub 2013 Sep 5. J Cancer Res Clin Oncol. 2013. PMID: 24005418

9

An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells.

Fang L, Cheng Q, Bai J, Qi YD, Liu JJ, Li LT, Zheng JN. Fang L, et al. Among authors: zheng jn. Mol Med Rep. 2013 Nov;8(5):1416-24. doi: 10.3892/mmr.2013.1680. Epub 2013 Sep 13. Mol Med Rep. 2013. PMID: 24042845

10

Diverse roles of C-terminal Hsp70-interacting protein (CHIP) in tumorigenesis.

Sun C, Li HL, Shi ML, Liu QH, Bai J, Zheng JN. Sun C, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2014 Feb;140(2):189-97. doi: 10.1007/s00432-013-1571-5. Epub 2013 Dec 27. J Cancer Res Clin Oncol. 2014. PMID: 24370685 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters